These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1588993)

  • 21. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 22. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
    Notter RH; Shapiro DL
    Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful surfactant treatment in idiopathic respiratory distress syndrome].
    Robertson B
    Lakartidningen; 1982 Jan; 79(4):217-20. PubMed ID: 6896355
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of severe respiratory distress syndrome treated with a surfactant of porcine origin (curosurf)].
    Valls i Soler A; Román Echevarría L; Setién Aqueche G; López Heredia de Goya J
    An Esp Pediatr; 1990 Aug; 33(2):160-2. PubMed ID: 2275499
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of natural surfactants to prevent and treat respiratory distress syndrome.
    Spafford PS; Kendig JW; Maniscalco WM
    Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443
    [No Abstract]   [Full Text] [Related]  

  • 28. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 29. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Saugstad OD
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):987-8. PubMed ID: 8191480
    [No Abstract]   [Full Text] [Related]  

  • 30. Pumactant and poractant alfa in respiratory distress syndrome.
    Morley C
    Lancet; 2000 Aug; 356(9231):765; author reply 766. PubMed ID: 11085710
    [No Abstract]   [Full Text] [Related]  

  • 31. Composition and function of pulmonary surfactant and its implication in respiratory distress syndrome of the neonate.
    Morris DC
    Ohio Med; 1990 Jul; 86(7):547-50. PubMed ID: 2392271
    [No Abstract]   [Full Text] [Related]  

  • 32. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant.
    Nelson RM
    Nebr Med J; 1992 May; 77(5):109-11. PubMed ID: 1407215
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of surfactant replacement therapy on neonatal mortality rates in Japan].
    Shirasaya K; Shimada N; Miyakawa M; Kondo T
    Nihon Koshu Eisei Zasshi; 1995 Dec; 42(12):1083-90. PubMed ID: 8835019
    [No Abstract]   [Full Text] [Related]  

  • 35. Pumactant and poractant alfa in respiratory distress syndrome.
    Wardhaugh AD; Matthes JW
    Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulmonary surfactant: physiology, pharmacology and clinical uses.
    Morton NS
    Br J Hosp Med; 1989 Jul; 42(1):52-8. PubMed ID: 2673470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute respiratory distress syndrome--effective therapeutic methods, at last?].
    Skeie B
    Tidsskr Nor Laegeforen; 1996 Apr; 116(10):1208-9. PubMed ID: 8658389
    [No Abstract]   [Full Text] [Related]  

  • 38. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of surfactants in 2009.
    Sweet DG; Halliday HL
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):78-83. PubMed ID: 19460896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.